1. Mesothelial or monocytic incidental cardiac excrescence on anterior leaflet of mitral valve
- Author
-
Francesca Sanvito, Elisabetta Lapenna, Cinzia Trumello, Claudio Doglioni, Sabrin Abboud, Michele De Bonis, Ottavio Alfieri, Alessandro Castiglioni, Abboud, S., Trumello, C., Sanvito, F., Lapenna, E., Castiglioni, A., Alfieri, O., Doglioni, C., and De Bonis, M.
- Subjects
mitral valve ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,030204 cardiovascular system & hematology ,Fibrin ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,mesothelial/monocytic incidental cardiac excrescence ,Mitral valve ,medicine ,Histiocyte ,biology ,business.industry ,Myxoma ,Excrescence ,medicine.disease ,Surgery ,Cardiac surgery ,medicine.anatomical_structure ,030228 respiratory system ,Cardiac chamber ,cardiovascular system ,biology.protein ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Mesothelial or monocytic incidental cardiac excrescence (MICE) is a rare, benign lesion composed of a mixture of mesothelial and inflammatory cells, histiocytes and fibrin without a vascular network usually accidentally found during cardiac surgery or after cardiac catherization. We report the case of a 45-year-old man admitted for suspected myxoma on the mitral valve. The lesion was removed via a minimally invasive video-assisted approach, without compromising the valve competency. The histopathological exam led to the diagnosis of MICE. The 2-yearfollow-up echocardiography confirmed normal mitral function without recurrence. Most of the cases were treated concomitantly to other cardiac procedure, lesions were more frequently founded in the left cardiac chambers or valves, our experience suggest that these lesions should be safely treated alone by surgical removal, to prevent embolic events.
- Published
- 2020
- Full Text
- View/download PDF